Individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher with at least one weight-related comorbidity, such as type 2 diabetes or hypertension, might be considered as potential candidates for Tesofensine therapy once it becomes available
Standard GLP-1 receptor agonist therapy uses once-weekly injections, with dose escalation from 0.25 mg up to 2.4 mg over 45 months
It helps you feel full sooner and eat less
BPC-157 Tissue Repair and Recovery While not directly targeting fat burning, BPC-157 helps repair tissues and reduce inflammation, supporting overall recovery and muscle repair, which is essential when working toward a leaner body
Phase 1: GLP-1 Foundation (Weeks 1 through 4) Start your GLP-1 medication at its lowest dose
POWERED BY GLYTEINE: Continual-G is the only supplement in the world which is powered by Glyteine, a proprietary form of gamma-glutamylcysteine, the immediate cellular glutathione precursor inside your cells
